Common stock

Mullen Automotive Inc. Announces 1-for-9 Reverse Stock Split effective August 11, 2023

Retrieved on: 
Thursday, August 10, 2023

BREA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Mullen Automotive Inc. (NASDAQ: MULN ) (“Mullen” or the “Company”), an emerging electric vehicle manufacturer, announced today that it will effect a 1-for-9 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on August 11, 2023, at 12:01 a.m., Eastern Time.

Key Points: 
  • BREA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Mullen Automotive Inc. (NASDAQ: MULN ) (“Mullen” or the “Company”), an emerging electric vehicle manufacturer, announced today that it will effect a 1-for-9 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001 per share (“Common Stock”), that will become effective on August 11, 2023, at 12:01 a.m., Eastern Time.
  • The new CUSIP number for the Common Stock following the Reverse Stock Split will be 62526P 307.
  • The 1-for-9 reverse stock split will automatically combine and convert nine current shares of the Company’s Common Stock into one issued and outstanding share of Common Stock.
  • The Reverse Stock Split will not change the par value of the Common Stock nor the authorized number of shares of Common Stock, preferred stock or any series of preferred stock.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Hub Cyber Security Ltd. f/k/a Hub Cyber Security (Israel) Ltd. of Class Action Lawsuit and Upcoming Deadline - HUBC; HUBCZ; HUBCW; RNER; RNERU; RNERW

Retrieved on: 
Thursday, August 10, 2023

Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Key Points: 
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Before the Merger, Mount Rainier's common stock, units, and redeemable warrants traded on the Nasdaq Stock Market ("NASDAQ").
  • Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

AxonPrime Infrastructure Acquisition Corporation Announces plan to Liquidate

Retrieved on: 
Thursday, August 10, 2023

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) -- AxonPrime Infrastructure Acquisition Corporation (the “Company”) today announced that it will not be able to consummate an initial business combination by August 17, 2023.

Key Points: 
  • NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) -- AxonPrime Infrastructure Acquisition Corporation (the “Company”) today announced that it will not be able to consummate an initial business combination by August 17, 2023.
  • Accordingly, promptly after August 17, 2023, the Company intends to liquidate in accordance with the provisions of its Second Amended and Restated Certificate of Incorporation.
  • Beneficial owners of the shares of common stock held in “street name” will not need to take any action in order to receive the redemption amount.
  • The Company’s sponsor waived its liquidation rights with respect to its outstanding common stock issued prior to the Company’s initial public offering.

Ralph Lauren Reports First Quarter Fiscal 2024 Results and Reiterates Full Year Outlook

Retrieved on: 
Thursday, August 10, 2023

In the first quarter of Fiscal 2024, revenue increased slightly to $1.5 billion on a reported basis and was up 1% in constant currency.

Key Points: 
  • In the first quarter of Fiscal 2024, revenue increased slightly to $1.5 billion on a reported basis and was up 1% in constant currency.
  • Operating income for the first quarter of Fiscal 2024 was $166 million and operating margin was 11.1% on a reported basis.
  • Net income in the first quarter of Fiscal 2024 was $132 million, or $1.96 per diluted share on a reported basis.
  • To access the conference call, listeners should dial in by 8:45 A.M. Eastern and request to be connected to the Ralph Lauren First Quarter 2024 conference call.

Tango Therapeutics Announces $80 million Private Placement Financing

Retrieved on: 
Thursday, August 10, 2023

The financing is expected to close on Friday, August 11, 2023, subject to customary closing conditions.

Key Points: 
  • The financing is expected to close on Friday, August 11, 2023, subject to customary closing conditions.
  • Gross proceeds from the private placement are anticipated to be approximately $80 million, before deducting any offering-related expenses.
  • The financing was led by Nextech with participation from Boxer Capital, Bain Capital Life Sciences, Casdin Capital, EcoR1 Capital, Southpoint Capital, Third Rock Ventures and a large institutional investor.
  • This financing underscores the confidence in our near-term clinical programs, and our state-of-the-art target platform to discover and develop new drugs for people with cancer,” said Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics.

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023

Retrieved on: 
Thursday, August 10, 2023

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today reported corporate updates and financial results for its fiscal first quarter ended June 30, 2023.

Key Points: 
  • NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today reported corporate updates and financial results for its fiscal first quarter ended June 30, 2023.
  • Immunovant is studying batoclimab, the company’s lead subcutaneously administered FcRn inhibitor, in four autoimmune indications – MG, TED, CIDP and GD.
  • Top-line data from the Phase 3 clinical trial in MG are expected in the second half of calendar year 2024.
  • R&D Expenses: Research and development expenses were $50.6 million for the three months ended June 30, 2023, compared to $28.4 million for the three months ended June 30, 2022.

Flywire Announces Pricing of Follow-On Offering

Retrieved on: 
Thursday, August 10, 2023

BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced the pricing of its underwritten public offering of 8,000,000 shares of its voting common stock (the “Common Stock”) at a price to the public of $32.00 per share.

Key Points: 
  • BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced the pricing of its underwritten public offering of 8,000,000 shares of its voting common stock (the “Common Stock”) at a price to the public of $32.00 per share.
  • Closing of the offering is expected to occur on August 14, 2023, subject to customary closing conditions.
  • In addition, Flywire has granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock at the public offering price less the underwriting discounts and commissions.
  • J.P. Morgan, Citigroup, BofA Securities, Raymond James, RBC Capital Markets and William Blair are acting as book-running managers for the offering.

Flywire Launches Proposed Follow-On Offering

Retrieved on: 
Wednesday, August 9, 2023

BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced the launch of a proposed follow-on public offering of $250,000,000 of shares of its voting common stock (the “Common Stock”).

Key Points: 
  • BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced the launch of a proposed follow-on public offering of $250,000,000 of shares of its voting common stock (the “Common Stock”).
  • In addition, Flywire expects to grant the underwriters a 30-day option to purchase up to an additional $37,500,000 of shares of Common Stock from Flywire at the public offering price less the underwriting discounts and commissions.
  • The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • Goldman Sachs & Co. LLC is acting as lead book-running manager for the offering.

Tigo Energy, Inc. Announces Redemption of Warrants

Retrieved on: 
Wednesday, August 9, 2023

This performance threshold was achieved following the market close on August 4, 2023.

Key Points: 
  • This performance threshold was achieved following the market close on August 4, 2023.
  • At the direction of the Company, Continental Stock Transfer & Trust Company, in its capacity as warrant agent, has mailed a notice of redemption to each of the registered holders of the outstanding Warrants.
  • Holders of Warrants in “street name” should immediately contact their broker to determine their broker’s procedure for exercising their Warrants since the process to exercise is voluntary.
  • Questions concerning redemption and exercise of the Warrants can be directed to Continental Stock Transfer & Trust Company, 1 State Street, 30th Floor, New York, New York 10004, Attention: Compliance Department, telephone number (212) 509-4000.

UMH PROPERTIES, INC. REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2023

Retrieved on: 
Tuesday, August 8, 2023

Samuel A. Landy, President and CEO, commented on the results of the second quarter of 2023.

Key Points: 
  • Samuel A. Landy, President and CEO, commented on the results of the second quarter of 2023.
  • The strength of our operating results has increased our bottom line results as evidenced by our sequential Normalized FFO growth.
  • Senior management will discuss the results, current market conditions and future outlook on Wednesday, August 9, 2023, at 10:00 a.m. Eastern Time.
  • The Company’s 2023 second quarter financial results being released herein will be available on the Company’s website at www.umh.reit in the “Financials” section.